CoreWeave, Inc.
For the period ended Jun 30, 2025. Filed Aug 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 13, 2025
CRWV$48.73-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Loss
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Net loss | $(290,509) | $(323,021) | $(605,150) | $(452,269) |
| Other comprehensive income (loss): | ||||
| Unrealized gain (loss) on available-for-sale marketable securities, net | — | 27 | — | 85 |
| Change in fair value of derivatives, net | (271) | — | (271) | — |
| Total comprehensive loss | $(290,780) | $(322,994) | $(605,421) | $(452,184) |
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS’ EQUITY (DEFICIT)
| Redeemable ConvertiblePreferred Stock · Redeemable Class A CommonStock · Common Stock · TreasuryStock · AdditionalPaid-inCapital · AccumulatedOtherComprehensiveLoss · AccumulatedDeficit · TotalStockholders’Equity (Deficit) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount · Shares · Amount | |||||||||||||||||
| Balance, December 31, 2024 | 184,635 | $1,722,111 | — | $— | 232,887 | $1 | $(33,524) | $1,096,160 | $— | $(1,476,235) | $(413,598) | ||||||
| Series C redeemable convertible preferred stock accretion to redemption value | — | 29 | — | — | — | — | — | (29) | — | — | (29) | ||||||
| Cash dividend on Series C redeemable convertible preferred stock | — | — | — | — | — | — | — | (28,693) | — | — | (28,693) | ||||||
| Reclassification of warrants from liability to equity classified | — | — | — | — | — | — | — | 172,808 | — | — | 172,808 | ||||||
| Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and offering costs | — | — | — | — | 36,590 | — | — | 1,391,515 | — | — | 1,391,515 | ||||||
| Conversion of redeemable convertible preferred stock in connection with initial public offering | (184,635) | (1,722,140) | 29,874 | 1,163,159 | 155,112 | 1 | — | 558,981 | — | — | 558,982 | ||||||
| Issuance of common stock for contract incentive | — | — | — | — | 8,750 | — | — | 350,000 | — | — | 350,000 | ||||||
| Issuance of common stock upon settlement of restricted stock units | — | — | — | — | 911 | — | — | — | — | — | — | ||||||
| Tax withholdings on settlement of restricted stock units | — | — | — | — | (392) | — | — | (15,685) | — | — | (15,685) | ||||||
| Exercise of stock options | — | — | — | — | 1,675 | — | — | 2,794 | — | — | 2,794 | ||||||
| Stock-based compensation expense | — | — | — | — | — | — | — | 202,670 | — | — | 202,670 | ||||||
| Net loss | — | — | — | — | — | — | — | — | — | (314,641) | (314,641) | ||||||
| Balance, March 31, 2025 | — | — | 29,874 | 1,163,159 | 435,533 | 2 | (33,524) | 3,730,521 | — | (1,790,876) | 1,906,123 | ||||||
| Issuance of common stock upon underwriters' exercise of over-allotment option, net of underwriting discounts and commissions | — | — | — | — | 1,760 | — | — | 67,669 | — | — | 67,669 | ||||||
| Issuance of common stock and restricted stock awards for business combination | — | — | — | — | 19,174 | — | — | 928,900 | — | — | 928,900 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Issuance of replacement restricted stock units for business combination | — | — | — | — | — | — | — | 3,861 | — | — | 3,861 |
| Tax withholdings on issuance of common stock and restricted stock awards for business combination | — | — | — | — | (472) | — | — | (24,332) | — | — | (24,332) |
| Issuance of common stock upon settlement of restricted stock units | — | — | — | — | 1,811 | — | — | — | — | — | — |
| Tax withholdings on settlement of restricted stock units | — | — | — | — | (904) | — | — | (92,541) | — | — | (92,541) |
| Exercise of stock options | — | — | — | — | 1,275 | — | — | 1,744 | — | — | 1,744 |
| Stock-based compensation expense | — | — | — | — | — | — | — | 157,003 | — | — | 157,003 |
| Other comprehensive income (loss) | — | — | — | — | — | — | — | — | (271) | — | (271) |
| Net loss | — | — | — | — | — | — | — | — | — | (290,509) | (290,509) |
| Balance, June 30, 2025 | — | $— | 29,874 | $1,163,159 | 458,177 | $2 | $(33,524) | $4,772,825 | $(271) | $(2,081,385) | $2,657,647 |
| Redeemable ConvertiblePreferred Stock · Redeemable Class A CommonStock · Common Stock · TreasuryStock · AdditionalPaid-inCapital · AccumulatedOtherComprehensiveLoss · AccumulatedDeficit · TotalStockholders’Equity (Deficit) | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount · Shares · Amount | |||||||||||||||||||||||
| Balance, December 31, 2023 | 154,678 | $464,690 | — | $— | 203,520 | $1 | $(32,054) | $48,397 | $(148) | $(612,787) | $(596,591) | ||||||||||||
| Issuance of Series B redeemable convertible preferred stock | 4,483 | 25,000 | — | — | — | — | — | — | — | — | — | ||||||||||||
| Closing settlement of Series B tranche option | — | 69,598 | — | — | — | — | — | — | — | — | — | ||||||||||||
| Exercise of stock options | — | — | — | — | 215 | — | — | 45 | — | — | 45 | ||||||||||||
| Stock-based compensation expense | — | — | — | — | — | — | — | 10,181 | — | — | 10,181 | ||||||||||||
| Other comprehensive income (loss) | — | — | — | — | — | — | — | — | 58 | — | 58 | ||||||||||||
| Net loss | — | — | — | — | — | — | — | — | — | (129,248) | (129,248) | ||||||||||||
| Balance, March 31, 2024 | 159,161 | 559,288 | — | — | 203,735 | 1 | (32,054) | 58,623 | (90) | (742,035) | (715,555) | ||||||||||||
| Issuance of Series C redeemable convertible preferred stock, net of issuance costs of $3.0 million | 29,523 | 1,147,476 | — | — | — | — | — | — | — | — | — | ||||||||||||
| Series C redeemable convertible preferred stock accretion to redemption value | — | 14 | — | — | — | — | — | (14) | — | — | (14) | ||||||||||||
| Paid-in-kind dividend on Series C redeemable convertible preferred stock | — | 15,582 | — | — | — | — | — | (15,582) | — | — | (15,582) | ||||||||||||
| Exercise of stock options | — | — | — | — | 411 | — | — | 597 | — | — | 597 | ||||||||||||
| Repurchase of common stock for business combination | — | — | — | — | (2,105) | — | — | — | — | — | — | ||||||||||||
| Stock-based compensation expense | — | — | — | — | — | — | — | 9,608 | — | — | 9,608 | ||||||||||||
| Other comprehensive income (loss) | — | — | — | — | — | — | — | — | 27 | — | 27 | ||||||||||||
| Net loss | — | — | — | — | — | — | — | — | — | (323,021) | (323,021) | ||||||||||||
| Balance, June 30, 2024 | 188,684 | $1,722,360 | — | $— | 202,041 | $1 | $(32,054) | $53,232 | $(63) | $(1,065,056) | $(1,043,940) | ||||||||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.